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Atypical genital bleeding is the most common and serious mani-
festation in patients with advanced gynecologic malignancies. In the
1930s, Frederic F Mohs originated a method for the chemical ﬁxation
of a cutaneous tumor using 20% of zinc chloride (Mohs' paste), which
causes necrosis, but preserves microscopic details of the tissue (Mohs
et al., 1941). He developed a technique of micrographic tumor serial
excision as a chemosurgery technique (Mohs et al., 1941; Swanson,
1983). Nowadays, such a technique has become widely accepted as
the treatment option for primary or recurrent cutaneous neoplasms
(Swanson, 1983).
Recent reports show that hemostasis could be achieved using
Mohs' paste in a malignant wound including unresectable breast can-
cer and skin metastasis of various kinds of cancer (Kakimoto et al.,
2010). We describe a successful treatment using Mohs' paste for
life-threatening genital bleeding in a patient with recurrent cervical
cancer. This is an important case report with promising results for fu-
ture patients and this clearly provides evidence that Mohs' paste can
save a patient's life from fatal genital bleeding of the uterine cervix.
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55-year-old, multiparous woman was urgently referred to our hospital
with massive genital bleeding. One year earlier, the patient had under-
gone concurrent chemo-radiation (pelvic radiation and intra-cavitary
radiation) for FIGO stage IIIb squamous cell carcinoma of the uterine
cervix. However, she had a relapse in the uterine cervix four months
after ﬁnishing the initial treatment. She had been treatedwith systemic
chemotherapy using cisplatin and irinotecan. Computed tomography
demonstrated the presence of an irregular solid tumor 45 mm in diam-
eter in the uterine cervix. Her height and bodyweight were 149 cm and
50 kg, respectively.
On admission, serious vaginal bleeding from the cervical tumor
continued and the patient complained of pelvic pain. Her mental sta-
tus was altered because of the pain. She was in a state of hypovolemic
shock because of a 1300 mL or more blood loss. Blood pressure
and heart rate were 78/42 mm Hg and 120 b.p.m., respectively. Her
serum hemoglobin level was 5.4 g/dL and she received 8 units of red
blood cell transfusion. Vaginal examination revealed that the tumor
was fragile and inﬁltrating the whole vaginal wall. Copious oozing
of blood was observed from the dorsal side of the tumor in the
cervix with a penetrating odor. Although a vaginal pack was inserted
under intravenous fentanyl administration, the bleeding persisted
and exceeded the capacity of the gauze (Fig. 1).
Twelve hours after admission, Mohs' paste was directly applied to
the most actively-bleeding region of the tumor using a large pledget,
with care being taken not to apply it to the vagina, and soft pressure
was applied to the tumor for a few minutes (Fig. 2). Twenty-four
hours later, the pledget was removed and as much paste as possible
was wiped from the tumor surface. Complete hemostasis and amelio-
ration of the bad odor were achieved by single direct usage of Mohs'
paste. The tumor surface became hard and the vaginal discharge
almost disappeared. She was discharged 10 days after admission
(Fig. 3). Hemostasis lasted for more than six months and she died of
multiple organ failure but had no further vaginal bleeding.Comment
Hemostasis for massive genital bleeding is difﬁcult when the
vaginal stump or a cervical vascularity neoplasm disintegrates, partic-
ularly in progressive patients with recurrent cervical cancer. Tumor
inﬁltration through pathways of lower resistance such as tissue
planes, blood vessels, lymphatics, and perineural spaces can lead to
Fig. 1. Cervical tumor before applying Mohs' paste. Copious oozing of blood was mainly
observed from the dorsal side of the tumor in the cervix.
Fig. 3. Two weeks after applying Mohs' paste.
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plasm often causes massive fatal bleeding due to the destruction of
fragile blood vessels (Prommer, 2005).
In general, external palliative radiotherapy is considered when
hemostasis cannot be achieved by gauze tampons. Hypogastric artery
ligations or uterine artery embolization is also considered as a more
invasive treatment for fatal bleeding (Yalvac et al., 2002; Sobiczewski
et al., 2002).
Chemosurgery using zinc chloride paste preoperatively with in
situ ﬁxation is a process called ﬁxed tissue technique in dermatology
(Trost and Bailin, 2011). Although the ﬁxed tissue technique offers
a high cure rate, it takes some days to complete. Mohs' Surgery by
modifying the ﬁxed tissue technique without using zinc chloride
paste is practiced all over the world as part of a multidisciplinary ap-
proach to treat skin cancer (Trost and Bailin, 2011). Therefore, many
health professionals are unaware of the strong hemostatic effect of
zinc-chloride components on bleeding from a neoplasm (Kakimoto
et al., 2010). Braun et al. outlined some locations where the ﬁxed
tissue method may be the better choice, including (1) squamous cell
carcinomas invading deeply and around narrow spaces, (2) lesions
on highly vascular structures, such as the penis, and miscellaneous
situations for the palliative removal of large, unresectable neoplasms
(Braun, 1981).
Mohs' paste is made of a mixture of zinc chloride (50 g), distilled
water (25 mL), zinc starch (19 g), and glycerol (15 mL). Zinc chloride
in Mohs' paste changes into zinc ions by ulcerative exudate, and then
the zinc ions precipitate wound proteins. Tissues, vessels, and cell
membranes of bacteria are ﬁxed chemically. Glycerol is used to adjust
viscosity. This mixture can be preserved at room temperature in aFig. 2. Mohs' paste was directly applied to the tumor using a large pledget.plastic ointment tub for one year. Mohs' paste softens at body tem-
perature. This change should be taken into account during its applica-
tion. The preparation should be applied with plastic gloves in order
to prevent skin irritation (Kakimoto et al., 2010). Before Mohs' paste
application, fentanyl is routinely administered intravenously because
penetrative ﬁxation of zinc chloride paste has the effect of normal
skin stimulation and often causes irritant contact dermatitis accom-
panied by pain. Kakimoto et al. (2010) used Mohs' paste in ﬁve pa-
tients with bleeding due to breast cancer. This paste was effective in
all patients including a hemorrhagic shock patient on the ﬁrst appli-
cation. Bleeding control was maintained from three weeks to three
months or more. Odor and exudates were also reduced.
The eight palliative stage patients who received Mohs' paste as a
treatment for continuous genital bleeding showed great improve-
ment in their quality of life (Yanazume et al., in press). To our knowl-
edge using a MEDLINE search (search terms: Mohs paste or Mohs'
paste, bleeding or gynecology), this is the ﬁrst report on the success-
ful application of Mohs' paste for vaginal bleeding. Almost complete
hemostasis could be achieved using Mohs' paste in all patients. The
effect of Mohs' paste continued for four days to one year. None of
the patients died of genital bleeding. There were no side effects, ex-
cept for pain requiring opioids. This case report has not been included
in our previous report. The present case developed massive genital
bleeding complicated by hypovolemic shock following anti-cancer
chemotherapy. Mohs' paste achieved complete hemostasis with a
single application without any complications. Mohs' paste can be
easily integrated in outpatient clinic pharmacies because it uses
cheap materials. However, we have encountered only a small number
of subjects. Further extensive studies including side effects are neces-
sary and warranted.
Conﬂict of interest statement
None of the authors have a conﬂict of interest.
Acknowledgments
The authors thank Phillip Allen Suzuki for his critical comments on
this paper.
References
Braun III, M., 1981. The case forMohs' surgery by the ﬁxed-tissue technique. J. Dermatol.
Surg. Oncol. 7, 634–640.
Kakimoto, M., Tokita, H., Okamura, T., Yoshino, K., 2010. A chemical hemostatic tech-
nique for bleeding from malignant wounds. J. Palliat. Med. 13, 11–13.
Mohs, F.E., Sevringhaus, E.L., Schmidt, E.R., 1941. Conservative amputation of gangre-
nous parts by chemosurgery. Ann. Surg. 114, 274–282.
Prommer, E., 2005. Management of bleeding in the terminally ill patient. Hematology
10, 167–175.
49S. Yanazume et al. / Gynecologic Oncology Reports 4 (2013) 47–49Sobiczewski, P., Bidzinski, M., Derlatka, P., 2002. Laparoscopic ligature of the hypogas-
tric artery in the case of bleeding in advanced cervical cancer. Gynecol. Oncol. 84,
344–348.
Swanson, N.A., 1983. Mohs surgery. Technique, indications, applications, and the future.
Arch. Dermatol. 119, 761–773.
Trost, L.B., Bailin, P.L., 2011. History of Mohs surgery. Dermatol. Clin. 29, 135–139 (vii).Yalvac, S., Kayikcioglu, F., Boran, N., Tulunay, G., Kose, M.F., Bilgic, S., Haberal, A., 2002.
Embolization of uterine artery in terminal stage cervical cancers. Cancer Invest. 20,
754–758.
Yanazume, Y., Douzono, H., Yanazume, S., Kojima, N., Iio, K., Mukaihara, K., Douchi, T.,
in press. Clinical usefulness of Mohs' paste for genital bleeding from the uterine
cervix or vaginal stump in gynecologic cancer. J. Palliat. Med.
